创伤后外周转录组学、基因组学与相互作用组学整合识别PTSD与抑郁症症状的因果基因
该研究在两家医院急诊科招募创伤后个体,整合外周血转录组、基因组与相互作用组数据,采用集合覆盖与网络流算法识别与创伤后6个月PTSD或MDD症状相关的驱动因果基因,发现两类症状共享ESR1、RUNX1、PPARA和WWOX等因果基因,并分别识别出MDD相关11个、PTSD相关13个及两者共享22个驱动因果基因。
要点
- 创伤后外周血多组学整合可识别PTSD与MDD症状的驱动因果基因。
- MDD症状相关驱动因果基因11个,PTSD症状相关13个,两者共享22个。
- ESR1、RUNX1、PPARA、WWOX为PTSD与MDD共享的驱动因果基因。
核心结论
- 创伤后外周转录组、基因组与相互作用组整合分析识别出一组可能驱动PTSD或MDD症状发展的因果基因与通路。
研究设计与样本
- 两中心纵向观察性前瞻研究,在Grady Memorial医院与Jackson Memorial医院急诊科招募创伤后个体。
- 评估超过10000人,入组超过700名创伤后个体(平均创伤后5.3小时,范围0.5-12小时)。
- 366人有RNA表达数据与6个月随访数据,297人具备基因型、转录组与表型数据。
主要发现
- 最终获得MDD症状相关驱动因果基因11个、PTSD症状相关13个、PTSD和/或MDD相关22个。
- PTSD与MDD共享ESR1、RUNX1、PPARA和WWOX作为驱动因果基因,另有基因仅为PTSD或MDD的因果驱动基因。
- 部分识别出的因果通路此前已被提示与PTSD和MDD的生物学或遗传学以及杏仁核功能与恐惧调节的临床前模型相关。
关键数值与推荐
- 采用集合覆盖方法捕捉PTSD或抑郁转换患者与非转换创伤暴露对照的基因表达波动,以筛选疾病相关失调基因代表集。
- 对候选基因标注表达数量性状位点,并应用当前流算法变体识别潜在因果基因。
临床怎么用
- 提示创伤后早期外周血多组学整合可用于识别PTSD与MDD的候选生物学靶点与高风险个体。
- 共享因果基因ESR1、RUNX1、PPARA和WWOX提示PTSD与MDD可能存在共同病理机制。
局限性
- RNA表达与6个月随访数据仅 available 于366人,基因型、转录组与表型数据仅 available 于297人。
- 研究为观察性设计,识别出的因果基因为计算推断结果,需进一步实验验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Posttraumatic stress disorder (PTSD) is a debilitating syndrome with substantial morbidity and mortality that occurs in the aftermath of trauma. Symptoms of major depressive disorder (MDD) are also a frequent consequence of trauma exposure. Identifying novel risk markers in the immediate aftermath of trauma is a critical step for the identification of novel biological targets to understand mechanisms of pathophysiology and prevention, as well as the determination of patients most at risk who may benefit from immediate intervention. Our study utilizes a novel approach to computationally integrate blood-based transcriptomics, genomics, and interactomics to understand the development of risk vs. resilience in the months following trauma exposure. In a two-site longitudinal, observational prospective study, we assessed over 10,000 individuals and enrolled >700 subjects in the immediate aftermath of trauma (average 5.3 h post-trauma (range 0.5-12 h)) in the Grady Memorial Hospital (Atlanta) and Jackson Memorial Hospital (Miami) emergency departments. RNA expression data and 6-month follow-up data were available for 366 individuals, while genotype, transcriptome, and phenotype data were available for 297 patients. To maximize our power and understanding of genes and pathways that predict risk vs. resilience, we utilized a set-cover approach to capture fluctuations of gene expression of PTSD or depression-converting patients and non-converting trauma-exposed controls to find representative sets of disease-relevant dysregulated genes. We annotated such genes with their corresponding expression quantitative trait loci and applied a variant of a current flow algorithm to identify genes that potentially were causal for the observed dysregulation of disease genes involved in the development of depression and PTSD symptoms after trauma exposure. We obtained a final list of 11 driver causal genes related to MDD symptoms, 13 genes for PTSD symptoms, and 22 genes in PTSD and/or MDD. We observed that these individual or combined disorders shared ESR1, RUNX1, PPARA, and WWOX as driver causal genes, while other genes appeared to be causal driver in the PTSD only or MDD only cases. A number of these identified causal pathways have been previously implicated in the biology or genetics of PTSD and MDD, as well as in preclinical models of amygdala function and fear regulation. Our work provides a promising set of initial pathways that may underlie causal mechanisms in the development of PTSD or MDD in the aftermath of trauma.
引用
- Wuchty S, Myers AJ, Ramirez-Restrepo M, et al. Integration of peripheral transcriptomics, genomics, and interactomics following trauma identifies causal genes for symptoms of post-traumatic stress and major depression. Mol Psychiatry. 2021. PMID: 33963278. doi:10.1038/s41380-021-01084-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。